IL302865B1
Treatment of hidradenitis suppurativa using jak inhibitors
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2014343030A1 | Cites | United States of America | XY | Search report | 3,5-8,10 |
| WO2017143014A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-2,4,9,11-13 |
| CHEN, XUEJUN, ET AL., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORALLY ADMINISTERED RUXOLITINIB (INCB018424 PHOSPHATE) IN RENAL AND HEPATIC IMPAIRMENT PATIENTS., 31 December 2014 (2014-12-31) | Non-patent | – | – | Search report | – |
58 members in 35 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 62650600 | United States of America | – | |
| 201862650600 | United States of America | P | |
| 2019024998 | United States of America | W |
Members58
| Document | Office | Kind | |
|---|---|---|---|
| CA3095487A1 | Canada | A1 | |
| WO2019191684A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2019328739A1 | United States of America | A1 | |
| TW202002967A | Taiwan Province of China | A | |
| SG11202009441PA | Singapore | A | |
| AU2019245420A1 | Australia | A1 | |
| IL277538A | Israel | A | |
| ECSP20069416A | Ecuador | A | |
| BR112020019814A2 | Brazil | A2 | |
| CO2020013600A2 | Colombia | A2 | |
| EA202092343A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CL2020002512A1 | Chile | A1 | |
| EP3773593A1 | European Patent Office (EPO) | A1 | |
| KR20210018203A | Republic of Korea | A | |
| MA52219A | Morocco | A | |
| CN112423759A | China | A | |
| PE20210402A1 | Peru | A1 | |
| JP2021519775A | Japan | A | |
| PH12020551597A1 | Philippines | A1 | |
| CN113768927A | China | A | |
| CN113768934A | China | A | |
| US11304949B2 | United States of America | B2 | |
| US2022241286A1 | United States of America | A1 | |
| MX2020010322A | Mexico | A | |
| TW202310843A | Taiwan Province of China | A | |
| IL302865A | Israel | A | |
| MX2022012285A | Mexico | A | |
| UA127925C2 | Ukraine | C2 | |
| JP2024026074A | Japan | A | |
| TWI835786B | Taiwan Province of China | B | |
| IL277538B1 | Israel | B1 | |
| EP3773593B1 | European Patent Office (EPO) | B1 | |
| DK3773593T3 | Denmark | T3 | |
| FI3773593T3 | Finland | T3 | |
| PT3773593T | Portugal | T | |
| MA52219B1 | Morocco | B1 | |
| LT3773593T | Lithuania | T | |
| RS65624B1 | Serbia | B1 | |
| RS65624B1 | Serbia | B1 | |
| SI3773593T1 | Slovenia | T1 | |
| IL277538B2 | Israel | B2 | |
| PL3773593T3 | Poland | T3 | |
| EP4424328A2 | European Patent Office (EPO) | A2 | |
| SMT202400306T1 | San Marino | T1 | |
| ZA202202361B | South Africa | B | |
| ES2980497T3 | Spain | T3 | |
| AU2019245420B2 | Australia | B2 | |
| AU2024219822A1 | Australia | A1 | |
| HUE067471T2 | Hungary | T2 | |
| MD3773593T2 | Republic of Moldova | T2 | |
| EP4424328A3 | European Patent Office (EPO) | A3 | |
| HRP20240741T1 | Croatia | T1 | |
| MY206999A | Malaysia | A | |
| IL302865B1This record | Israel | B1 | |
| IL318069A | Israel | A | |
| US12280054B2 | United States of America | B2 | |
| IL302865B2 | Israel | B2 | |
| JP7720697B2 | Japan | B2 |
Numbers
- Publication
- 302865
- Application
- 302865
Titles2
- English
- TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS
- Hebrew
- שימוש במעכבי JAK לטיפול בהידרהדניטיס סופוראטיבה
Classification
- CPC, 13
- A61K31/519
- A61K31/4155
- A61K9/0014
- A61P17/10
- A61K31/437
- A61K9/0053
- A61K45/06
- A61P17/00
- A61K31/573
- A61P37/02
- A61P29/00
- A61P37/00
- A61K2300/00
- IPC, 6
- A61K45 06
- A61K31 519
- A61K31 437
- A61K31 573
- A61K31 4155
- A61P17 10